Literature DB >> 26843009

Cortical damage in the posterior visual pathway in patients with sialidosis type 1.

Chin-Song Lu1,2,3, Shu-Hang Ng4, Szu-Chia Lai1,2, Ling-Yuh Kao5,6, Laura Liu5,6, Wey-Yil Lin1,2, Yi-Ming Wu4,7, Yao-Liang Chen4,7, Jiun-Jie Wang8,9,10,11.   

Abstract

In order to identify the cortical changes in patients with Sialidosis type 1, diffusion tensor imaging and resting state fMRI were acquired from 11 patients and 11 sex/age matched normal controls after clinical evaluations. The neuroimages from each participant were normalized and parcellated according to the Automatic Anatomical Labeling. Both the mean diffusivity and the corresponding functional connectivity were calculated from each cortical region. The white matter tract integrity was examined. The difference between patients and controls was examined using Student's t-test and between patients with either homozygous or heterozygous mutations by Mann-Whitney U test, both at a threshold of 0.05. Increased mean diffusivity throughout the brain can be noticed in the patients, together with a compromised white matter tracts integrity. The most severely affected cortical regions are in the occipital lobe. Decreased functional connectivity was from the temporal and occipital lobes to the hippocampus and parahippocampus. In contrast, connectivity from thalamus was enhanced. Diffused cortical atrophy with posterior focal lesions was noticed. We concluded that MRI observed functional changes in the posterior cortical pathways in the patients with Sialidosis. The observation might be related to the cortical blindness due to an altered neural network and a compromised visual pathway in the patients.

Entities:  

Keywords:  Cortical blindness; Diffusion tensor imaging; Posterior visual pathway; Resting state fMRI; Sialidosis

Mesh:

Year:  2017        PMID: 26843009     DOI: 10.1007/s11682-016-9517-6

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  5 in total

1.  Clinical and genetic characteristics of type I sialidosis patients in mainland China.

Authors:  Rui-Juan Lv; Tao-Ran Li; Yu-Di Zhang; Xiao-Qiu Shao; Qun Wang; Li-Ri Jin
Journal:  Ann Clin Transl Neurol       Date:  2020-05-29       Impact factor: 4.511

Review 2.  NEU1-A Unique Therapeutic Target for Alzheimer's Disease.

Authors:  Aiza Khan; Consolato M Sergi
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

3.  Seizure triggered by flicker electroretinogram in a patient with no history of epilepsy.

Authors:  Sven P Heinrich; Hansjürgen Agostini
Journal:  Doc Ophthalmol       Date:  2020-12-23       Impact factor: 2.379

Review 4.  Keeping it trim: roles of neuraminidases in CNS function.

Authors:  Alexey V Pshezhetsky; Mila Ashmarina
Journal:  Glycoconj J       Date:  2018-08-07       Impact factor: 2.916

5.  Sialidosis type I presenting with a novel mutation and advanced neuroimaging features.

Authors:  Murat Gultekin; Ruslan Bayramov; Cagatay Karaca; Niyazi Acer
Journal:  Neurosciences (Riyadh)       Date:  2018-01       Impact factor: 0.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.